Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 10.50
0.00 (0.00%)
Feb 11, 2026, 2:39 PM CST
Pharmigene Market Cap
Pharmigene has a market cap or net worth of 529.88 million as of February 13, 2026. Its market cap has decreased by -30.92% in one year.
Market Cap
529.88M
Enterprise Value
1.07B
Revenue
149.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.50
Market Cap Chart
Since December 22, 2020, Pharmigene's market cap has decreased from 1.08B to 529.88M, a decrease of -51.04%. That is a compound annual growth rate of -12.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 529.88M | 6.06% |
| Dec 31, 2025 | 499.60M | -30.53% |
| Dec 31, 2024 | 719.13M | -31.16% |
| Dec 29, 2023 | 1.04B | 21.08% |
| Dec 30, 2022 | 862.78M | -8.53% |
| Dec 30, 2021 | 943.19M | -13.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 69.79B |
| EBM Technologies | 648.00M |
| TaiwanJ Pharmaceuticals | 616.94M |
| Vectorite Biomedical | 610.61M |
| Health & Life | 587.85M |